Asset managers could be set to cash in on Shire
Asset managers could be close to realising significant profits on shares held in pharmaceutical company Shire after its board finally agreed to deal talks with US suitor AbbVie.
Asset managers could be close to realising significant profits on shares held in pharmaceutical company Shire after its board finally agreed to deal talks with US suitor AbbVie.
